KRT17 and cancer: A growing body of evidence has shown that KRT17 is abnormally expressed in a variety of human malignant tumours, suggesting that KRT17 is an oncogene (Liu et al., 2018; Chen et al., 2020; Chivu-Economescu et al., 2017).